Hematopoietic Stem Cell Transplantation Market Report 2026

Hematopoietic Stem Cell Transplantation Market Overview

• Hematopoietic Stem Cell Transplantation market size has reached to $5.1 billion in 2025 • Expected to grow to $8.57 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Rising Blood Cancer Incidence Fuels Growth In The Hematopoietic Stem Cell Transplantation Market • Market Trend: A Digital Resource For Hematopoietic Stem Cell Transplantation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hematopoietic Stem Cell Transplantation Market?

Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient's damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient's body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood. The main types of cells in hematopoietic stem cell transplantation are allogeneic and autologous. Allogeneic refers to a type of stem cell transplant in which the donor and recipient are different individuals with different genetic makeup. It was used to treat various indications such as leukemia, lymphatic disorders, myeloma, and others, and these are used for several applications, including bone marrow transplants, peripheral blood stem cell transplants, and cord blood transplants. The main end-users are hospital pharmacies, retail pharmacies, and specialty clinics.

What Is The Hematopoietic Stem Cell Transplantation Market Growth Forecast?

The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $8.57 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing adoption of gene-modified stem cell therapies, rising investments in transplant infrastructure, expansion of allogeneic transplant procedures, growing focus on personalized transplant approaches, increasing survival rates post-transplant. Major trends in the forecast period include increasing adoption of peripheral blood stem cell transplants, rising use of cord blood transplantation, growing integration of precision conditioning regimens, expansion of donor registry networks, enhanced focus on post-transplant monitoring.

Global Hematopoietic Stem Cell Transplantation Market Segmentation

1) By Type: Allogeneic, Autologous 2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders 3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant 4) By End User: Hospital Pharmacy, Specialty Clinics Subsegments: 1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation 2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation

What Is The Driver Of The Hematopoietic Stem Cell Transplantation Market?

The increased frequency of blood cancer is expected to propel the growth of the hematopoietic stem cell transplantation market. A group of malignancies that impact the development and operation of blood cells are referred to as blood cancers. Leukemia, lymphoma, and myeloma are the three main types of blood cancer. By replacing stem cells and bone marrow cells that have been killed by the malignancy, hematopoietic stem cell transplantation is generally used to treat blood cancer. These new stem cells can then move to the bone marrow and start creating new blood cells. So, these factors boost the hematopoietic stem cell transplantation market. For instance, in September 2025, according to Cancer Research UK, a UK-based charity, From 2024 to 2026, the incidence rate of leukemia in the UK is estimated at approximately 17.9 cases per 100,000 people per year, and it is projected to decrease by 3% to around 17.4 per 100,000 by 2038 to 2040. Therefore, the increased frequency of blood cancer drives the hematopoietic stem cell transplantation industry.

Key Players In The Global Hematopoietic Stem Cell Transplantation Market

Major companies operating in the hematopoietic stem cell transplantation market are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

Global Hematopoietic Stem Cell Transplantation Market Trends and Insights

Major companies operating in hematopoietic stem cell transplantation are focusing on developing innovations such as digital resources to streamline patient management, enhance donor matching processes, and provide real-time data analytics for better decision-making. Digital resources refer to various online tools, platforms, or materials that provide information, services, or functionalities in a digital format. For instance, in September 2024, BioLineRx Ltd., an Israel-based biopharmaceutical company, launched Mobilization Matters, a digital resource. Mobilization Matters is an interactive platform designed to educate healthcare professionals and patients about the mobilization of stem cells for transplantation. It offers comprehensive guidelines, best practices, and real-time tracking tools to optimize the stem cell collection process, thereby improving patient outcomes and ensuring efficient use of resources in transplantation procedures.

What Are Latest Mergers And Acquisitions In The Hematopoietic Stem Cell Transplantation Market?

In June 2024, BlueSphere Bio, a US-based biotechnology company, formed a partnership with NMDP BioTherapies to advance the company’s first-in-human TCR-based product candidate in combination with allogeneic hematopoietic cell transplantation. The collaboration aims to evaluate the safety and efficacy of the novel therapy, accelerate clinical development, and expand treatment options for patients with hematologic malignancies, while fostering innovation in the cell and gene therapy market. NMDP BioTherapies is a US-based nonprofit organization specializing in the manufacturing and development of cellular therapies for transplantation and immunotherapy applications.

Regional Outlook

North America was the largest region in the hematopoietic stem cell transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hematopoietic Stem Cell Transplantation Market?

The hematopoietic stem cell transplantation (HSCT) market includes revenues earned by entities providing services such as medical evaluation, pre-transplant care, stem cell collection and processing, transplantation procedures, post-transplant care, supportive care, and long-term follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hematopoietic Stem Cell Transplantation Market Report 2026?

The hematopoietic stem cell transplantation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hematopoietic stem cell transplantation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.